Lonza to up Moderna Covid jab output with Dutch production line

Swiss firm Lonza will open a new production line for the drug substance in Moderna’s Covid-19 vaccine, making it possible to churn out hundreds of millions more jabs per year.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.